Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A) antibody

Antigen

Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A)

Synonyms DR4, APO2, CD261, MGC9365, TRAILR1, TRAILR-1, TNFRSF10A
Clonality Monoclonal (DR-4-02)
Host
Alternatives

Mouse

Reactivity
Alternatives

Human

Application
Alternatives Flow Cytometry (FACS), Immunoprecipitation (IP), Functional Studies (Func), Immunocytochemistry (ICC)
1 reference available
Catalog no. ABIN94303
Quantity 0.1 mg  (1 mg/ml)
Price 325.00 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 3 to 5 Business Days

Additional Information

Alternative name CD261 / TRAIL-R1
Immunogen Fusion protein containing the extracellular part of TRAIL-R1 and the constant part of theheavy chain of the human IgG1.
Format Azide Free
Isotype IgG1  (Matching secondary antibodies)
Clone DR-4-02
Description TRAIL-R1 (CD261, DR4) is a type I transmembrane protein, also called TRAIL receptor 1.The ligand for this DR4 death receptor has been identified and termed TRAIL, which is amember of the TNF family. DR4, as many other receptors (Fas, TNFR1, etc.), mediatesapoptosis and NF kappaB activation in many cells and tissues.Apoptosis, a programmed cell death, is a operating process in normal cellulardifferentiation and development of multicellular organisms. Apoptosis is induced by coupledof certain cytokines (TNF family - TNF, Fas ligand) and their death domain containingreceptors (TNFR1, Fas receptor).
Specificity The antibody DR-4-02 recognizes TRAIL-R1 (DR4), a human death receptor 4 (468 aminoacids) expressed in most human tissues (spleen, peripheral blood leucocytes, thymus) andin a variety of tumour-derived cell lines.

Application Details

Application Notes Flow Cytometry: Recommended dilution: 3-5 µg/ml ImmunoprecipitationImmunocytochemistryFunctional ApplicationSoluble antibody DR-4-02 blocks apoptosis triggered by a ligand (TRAIL). Plastic-immobilized (cross-linked) DR-4-02 antibody induces apoptosis in sensitive cells. Recommended dilution of antibody: 2-3 µg/ml in cultivation medium Final concentration of TRAIL: 20-200 ng/ml. Application note: It is recommended to add the antibody 15 min before addition of TRAIL.
Concentration 1 mg/ml
Purity > 95% (by SDS-PAGE)
Purification Purified from hybridoma culture supernatant by protein A-affinity chromatography.
Buffer Azide free phosphate buffered saline (PBS), approx. pH 7.4, 0.2 µ m filter sterilized.
Storage Store at 2-8 o C. Do not use after expiration date stamped on vial label. For long-term storage aliquot and store at -20 o C. Avoid freeze/thaw cycles.
Restrictions For Research Use only

Publications

Publications Suimovua, Kluima, Cermak et al.: "Arf and Rho GAP adapter protein ARAP1 participates in the mobilization of TRAIL-R1/DR4 to the plasma membrane." in: Apoptosis : an international journal on programmed cell death, Vol. 13, Issue 3, pp. 423-36, 2008 (PubMed).

Alternatives

Alternatives for antigen "Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A)", type "Antibodies"
Hosts Rabbit (19), Mouse (18), Goat (1)
Reactivities Human (36), Mouse (Murine) (3), Rat (Rattus) (3)
Applications Western Blotting (WB) (27), Flow Cytometry (FACS) (13), Enzyme Immunoassay (EIA) (8), Immunofluorescence (IF) (7), Immunoprecipitation (IP) (6), Functional Studies (Func) (4), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (3), ELISA (2), Immunohistochemistry (IHC) (1)
Conjugates FITC (2), PE (2)
Epitopes AA 427-445 (1), C-Term (1), N-Term (1)